Big Pharma admits mRNA injections are gene therapies
InfoWars host (
https://bit.ly/3vYRmIU) Owen Shroyer scoffed
at the arrogance of people behind the experimental Wuhan
coronavirus (COVID-19) injections.
We were reporting, and other outlets were reporting, that this
was an mRNA technology. And they said, No, its not, theres
no mRNA shot, theres no mRNA, theres no mRNA in these
shots. Now they just promoted it as mRNA. Its like they expect
us to not have a memory or something, said Shroyer during a
recent episode of The Alex Jones Show.
Shroyer actually meant to say gene therapy instead of mRNA, but
you get the point. Big Pharma is making a fool out of everyone.
Filling in for regular host Alex Jones, Shroyer played a video clip
in which a Bayer executive essentially admitted that Big Pharma
deceived people into taking the mRNA injections.
In the video, Bayer Pharmaceuticals Division President Stefan
Oelrich said were it not for the pandemic, the experimental
injection may have seen an extremely high rejection rate.
Oelrich made the statement at the opening of the World Health
Summit 2021 last November. Ultimately, the mRNA vaccines
are an example of that cell and gene therapy, Oelrich said at
the time.
He also admitted that 95 percent of people would probably refuse
gene therapy under normal circumstances. I think this pandemic
has opened many peoples eyes to innovation, he said.
But even after Oelrichs statement, some media outlets maintained
their stance that the mRNA injections are not gene therapies.
On January 4, Forbes published an article titled Pfizer and Moderna
mRNA vaccines are not gene therapies.
Poynter.org even published a fact-check claiming that the Bayer
executive did not actually say that the mRNA vaccines are cell
and gene therapies.
Oelrich did not say that mRNA vaccines against the COVID-19 are
a gene or cell therapy. What he did point out is that mRNA-based
vaccines are an example of technological innovation, just as the gene
and cell therapy proposed by Bayer are an example of technological
innovation, it said.